Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

Moderna

01.07.21

Moderna’s COVID-19 Vaccine Becomes Second to Nab EU Authorization

Source: FirstWord

01.05.21

FDA Knocks Proposals to Tinker With COVID-19 Vaccine Regimens

Source: FirstWord

01.05.21

Moderna Boosts COVID-19 Vaccine Output for 2021 to at Least 600 Million Doses

Source: Moderna

12.18.20

FDA Panel Endorses Moderna’s COVID-19 Vaccine for Emergency Use

Source: FirstWord

12.17.20

Vaccine Rollout On Track, Expect 300M Doses Through March: Feds

Source: Medscape

12.16.20

FDA Review Confirms Efficacy of Moderna’s mRNA-1273 Vaccine Against COVID-19

Source: FirstWord

12.14.20

US Government to Buy 100 Million More Doses of Moderna’s COVID-19 Vaccine

Source: FirstWord

11.30.20

Moderna’s mRNA COVID-19 Vaccine 94.1% Effective at Final Analysis

Source: FirstWord

11.19.20

Azar Expects 40M COVID-19 Vaccine Doses Ready to Distribute By End of December

Source: FierceHealthcare

11.16.20

Moderna Says mRNA COVID-19 Vaccine 94.5% Effective

Source: FirstWord

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.